🇺🇸 Rifampin-combination therapy in United States

Rifampin-combination therapy (Rifampin-combination therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Rifampin-combination therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rifampin-combination therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rifampin-combination therapy in United States?

Oslo University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.